维普中文期刊产品整合服务
87篇 您的检索式:作者名="MANENTI L"
    题名 作者 年代 出处 被引量
1Matrix metalloproteinase (MMP-9 and MMP-2) induce the release of vascular endothelial growth factor by overian carcinoma cell: implications for ascites formation显示文摘Belotti D Pagunoi P Manenti L 2003Cancer Res2003,63,:1
2Matrix metaloproteases(MMP9 and MMP2)induce the release of(vascular endothelial growth factor(VEGF)by ovarian carcinoma cells显示文摘 Paganoni P Manenti L 2003Cancer Res2003,63,17:1
3Idiopathic retroperitoneal fi- brosis 显示文摘Greco P Vaglio A Manenti L 2004G hal Nefro12004,21,:1
4Evidence of autoim- munity in chronic periaortitis: a prospective study 显示文摘Vaglio A Corradi D Manenti L 2003Am J Med2003,114,6:1
5Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma显示文摘Manenti L Paganoni P Floriani I 2003Eur J Cancer2003,39,:1
6Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy显示文摘Manenti L Riccardi E Marchini S 2005Mol Cancer Ther2005,4,5:1
7Pure red cell aplasia followed by disseminated intravascular coagulation in a haemodialysis patient receiving erythropoietin显示文摘MANENTI L VAGLIO A 2007Nephrol Dial Transpl2007,22,5:1
8Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition显示文摘Agullo G Gamet-Payrastre L Manenti S 1997Biochemical Pharmacology1997,53,12:1
9Relationship between flavonoid structure and inhibition of phosphatidylinositol 3- kinase: a comparison with tyrosine kinase and protein kinase C inhibition显示文摘Agullo G Gamet-Payrastre L Manenti S 1997Biochem Pharmacol1997,53,:1
10Uraemic pruritus: clinical characteristics, pathophysiology and treatment显示文摘Manenti L Tansinda P Vaglio A 2009Drugs2009,69,3:1
11Expression levels of vascular endothelial growth factor, matrix metall oprotein- ases 2 and 9 and tissue inhibitor of metall oproteinases 1 and 2 in the plasma of with ovarian careinoma显示文摘Manenti L Paganoni P Floriani I 2007Eur J Cancer Inst2007,39,1:1
12Idiopathic retroperitoneal fibrosis显示文摘Greco P Vaglio A Manenti L 0,,02:1
13Gabapentin in the treatment of uremic itch: an Index case and pilot evaluation 显示文摘Manenti L Vaglio A Costantio E 2005JAm Soc Nephrol2005,18,:1
14Idiopathic retro peritoneal fibrosis显示文摘Greco P Vaglio A Manenti L 0,,02:1
15Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase:a comparison with tyrosine kinase and protein kinase C inhibition显示文摘Agullo G Gamet-Payrastre L Manenti S 1997Biochem Pharmacol1997,53,11:1
16Characterization of the biophysical properties of human erythroblasts as a prelimi- nary step to the isolation of fetal erythroblasts from materi- al peripheral blood for noninvasive prenatal genetic inves- tigation 显示文摘Sitar G Manenti L Farina A 1997Haematologica1997,82,1:1
17Expression level of vascular endothelial growth factor,matrix metalloproteinase 2 & 9 and tissue inhibitor of metalloproteinases 1 & 2 in plasma of patients with ovarian carcinoma显示文摘Manenti L Paganoni P Floriani I 2003Eur J Cancer2003,39,13:1
18Matrix metal- loproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor(VEGF)by ovarian carcinoma cells : implications for ascites formation显示文摘Belotti D Paganoni P Manenti L 2003Cancer Res2003,63,17:1
19EBV-associated leukoencephalopathy with late onset of central nervous system lymphoma in a kidney transplant recipient显示文摘Vaglio A Manenti L Mancini C 0,,04:1
20Idiopathic retroperitoneal fibrosis显示文摘 Vaglio A Manenti L 2004G Ital Nefrol2004,21,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费